News

Embecta: Not Nearly As Cheap As The 4x Forward P/E Ratio Would Imply
Embecta stock may seem undervalued at first glance, but heavy debt, declining pen needle revenues, and competition signal ...
Avadel Pharmaceuticals: Moving Nicely Through An 'Inflection Year'
Avadel Pharmaceuticals is gaining momentum with strong Q1 results, a key legal win, and moving swiftly to profitability. Read ...
Calculating The Intrinsic Value Of Lycopodium Limited (ASX:LYL)
Using the 2 Stage Free Cash Flow to Equity, Lycopodium fair value estimate is AU$13.51 Lycopodium's AU$10.99 share price indicates it is trading at similar levels as its fair value estimate Industry ...